JAK2 and thyroid gland carcinoma: In thyroid cancer, the JAK2/STAT3 signaling pathway not only directly induces the EMT process and enhances cancer cell migration but also synergistically promotes VEGF-A secretion, thereby regulating tumor metastasis and angiogenesis.